Last updated on April 2019

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy


Brief description of study

The main purpose of this study is to determine whether nivolumab + chemotherapy is effective as compared to chemotherapy in the treatment of patients with EGFR mutation, NSCLC who failed first line (1L) or second-line (2L) EGFR TKI therapy.

Clinical Study Identifier: NCT02864251

Find a site near you

Start Over

Pacific Shores Medical Group

Long Beach, CA United States
  Connect »

UCLA Cancer Hematology Oncology

Los Angeles, CA United States
  Connect »

St Joseph Hospital

Orange, CA United States
  Connect »

Torrance Memorial Physican Network

Redondo Beach, CA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

Johns Hopkins University

Baltimore, MD United States
  Connect »

NYU Langone Medical Center

New York, NY United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

Texas Health Physicians Group

Fort Worth, TX United States
  Connect »

Local Institution

Hong Kong, Hong Kong
  Connect »

Local Institution

Hirosaki-shi, Japan
  Connect »

Local Institution

Matsuyama-shi, Japan
  Connect »

Local Institution

Yokohama-Shi, Japan
  Connect »

Local Institution

Kumamoto-shi, Japan
  Connect »

Local Institution

Kiriyama-shi, Japan
  Connect »

Local Institution

Hirakata-shi, Japan
  Connect »

Local Institution

Kishiwada shi, Japan
  Connect »

Local Institution

Osakasayama-shi, Japan
  Connect »

Local Institution

Kitaadachi-gun, Japan
  Connect »

Local Institution

Fukushima-shi, Japan
  Connect »

Local Institution

Cheogju-si, Korea, Republic of
  Connect »

Local Institution

Goyang, Korea, Republic of
  Connect »

Local Institution

Gyeonggi-do, Korea, Republic of
  Connect »

Local Institution

Inchoen, Korea, Republic of
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Local Institution

Singapore, Singapore
  Connect »

Local Institution

L'Hospitalet de Llobregat, Spain
  Connect »

Local Institution

Kaohsiung city, Taiwan
  Connect »

Local Institution

Yokohama-shi, Japan
  Connect »

Local Institution

Kaohsiung City, Taiwan
  Connect »

Local Institution

Taipei City, Taiwan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.